Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover air-stable 1,2,4-triazolyl arylamine synthesis. Eliminate anhydrous conditions, reduce costs, and ensure supply chain reliability for API development. (148 chars)
Reduce production costs by 30% with this Pd/C-catalyzed miglitol process. 99.9% purity, 97% yield, and no biological oxidation steps. Contact for CDMO scale-up.
Discover how this novel chiral synthesis method achieves >90% optical purity with low-cost reagents, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Solve low-yield challenges in discotic liquid crystal production. Our CDMO expertise in phase-transfer catalysis delivers 75%+ yields for organic solar cells. Request COA now.
Discover how recent patent breakthroughs in metal-free catalysis for branched 1,4-dienamide synthesis can reduce production costs and improve supply chain stability for pharmaceutical intermediates.
Avoid heavy metal catalysts and anhydrous conditions in 1,2,4-triazole synthesis. Achieve 72-97% yields with cheap starting materials. Reduce production costs and supply chain risks.
Discover a 90% yield, low-cost synthesis method for indolo-dihydrochromene antitumor compounds. Ideal for R&D and production scale-up. Contact us for custom synthesis.
Solve thioester synthesis challenges with novel Pd-catalyzed method using sulfonyl chloride. Reduce catalyst poisoning, improve yield, and ensure GMP compliance for API production.
Novel 3-trifluoromethyl-1,2,4-triazole method with 91% yield, low-cost reagents, and gram-scale capability. Solve pharma R&D and production challenges.
Discover how metal-free NHC-catalyzed synthesis of 4,6-disubstituted dihydropyran-2-ones eliminates heavy metal residues, reduces production costs, and ensures GMP compliance for your API manufacturing.
Solve 1,2,4-triazole synthesis challenges with iron-catalyzed method. Eliminate anhydrous conditions, reduce costs, and ensure scalable production for drug development.
Discover efficient synthesis of axial chiral indole-naphthalene compounds with >95% ee. Reduce production costs and scale up asymmetric catalysts for pharma R&D.
Efficient, high-yield synthesis of axial chiral indole-naphthalene compounds with >95% ee. Reduce R&D costs and supply chain risks for asymmetric catalysis applications.
Solve silodosin production challenges with 55.6% yield and 99.1% ee. Avoid difficult byproduct separation and reduce costs. CDMO expertise for scalable API manufacturing.
Solve metal catalyst issues in quinoline synthesis. Our metal-free, air-stable method cuts costs & risks. Scale to 100MT/yr with 99% purity. Contact for COA/MSDS.
Solve CO handling risks & low yields in quinazolinone synthesis. Discover how solid CO substitute enables safe, scalable production for drug development. Contact for custom synthesis.
Solve low-yield and long-cycle issues in Paxlovid intermediate production. Our CDMO expertise delivers 60%+ yield, 99% purity, and industrial-scale reliability.
Eliminate diazonium safety risks with this 80% yield, 99.5% purity process. Reduce wastewater and scale production reliably.
Discover how metal-free hydrodefluorination of trifluoromethyl olefins with 87% yield solves GMP compliance and supply chain risks for pharmaceutical intermediates.
Solve C-N bond construction challenges in heterocyclic synthesis with room-temperature amination. 90% yield, easy scale-up for API manufacturing.